Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004475 · ClinicalTrials.gov registry record
Genetic Linkage Study for Hereditary Pancreatitis
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 808
- Enrollment target
NCT00004475: Completed study, sponsored by University of Pittsburgh.
NCT00004475 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 808 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004475 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 808 participants
- Enrollment target
Study Summary
The purpose of this study is to establish linkage in families with hereditary pancreatitis (HP) to the cationic trypsinogen gene or other, as yet unknown, HP gene(s).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 808 participants |
| Start Date | 1998-12 |
| Est. Completion | 2022-12 |
What the finished NCT00004475 record still lists
NCT00004475 is an observational study that tracks outcomes without assigning an intervention. The registered 808 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00004475 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004475 about?
NCT00004475 is a clinical study titled "Genetic Linkage Study for Hereditary Pancreatitis". The purpose of this study is to establish linkage in families with hereditary pancreatitis (HP) to the cationic trypsinogen gene or other, as yet unknown, HP gene(s).
What is the current status of trial NCT00004475?
This trial is currently completed. The enrollment target is 808 participants. The study started on 1998-12. Estimated completion is 2022-12.
Who is sponsoring clinical trial NCT00004475?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06529094 · 808 participants · NA
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
- NCT05519085 · 810 participants · Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia